UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup

Intensive care medicine, 2020-04, Vol.46 (4), p.654-672

2020

Volltextzugriff (PDF)

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

Intensive care medicine, 2015-08, Vol.41 (8), p.1411-1423

2015

Volltextzugriff (PDF)

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not

Critical care (London, England), 2020-09, Vol.24 (1), p.1-553, Article 553

2020

Volltextzugriff (PDF)

Editorial: New insights in sepsis pathogenesis and renal dysfunction: Immune mechanisms and novel management strategies

Frontiers in immunology, 2023-03, Vol.14, p.1176620-1176620

2023

Volltextzugriff (PDF)

Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT

Critical care (London, England), 2023-02, Vol.27 (1), p.52-52, Article 52

2023

Volltextzugriff (PDF)

High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial

Intensive care medicine, 2013-09, Vol.39 (9), p.1535-1546

2013

Volltextzugriff (PDF)

Cytokine removal in human septic shock: Where are we and where are we going?

Annals of intensive care, 2019-05, Vol.9 (1), p.56-13, Article 56

2019

Volltextzugriff (PDF)

Editorial: Community series in new insights in sepsis pathogenesis and renal dysfunction: immune mechanisms and novel management strategies: volume II

Frontiers in immunology, 2023, Vol.14, p.1322571-1322571

2023

Volltextzugriff (PDF)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?

Critical care (London, England), 2020-07, Vol.24 (1), p.1-450, Article 450

2020

Volltextzugriff (PDF)

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure

Critical care (London, England), 2020-05, Vol.24 (1), p.226-226, Article 226

2020

Volltextzugriff (PDF)

Renal and neurological side effects of colistin in critically ill patients

Annals of intensive care, 2011-05, Vol.1 (1), p.14-7, Article 14

2011

Volltextzugriff (PDF)

Is prolonged intermittent renal replacement therapy actually safe for hemodynamically unstable patients

Critical care (London, England), 2023-04, Vol.27 (1), p.159-159, Article 159

2023

Volltextzugriff (PDF)

Anticoagulation Prophylaxis in Extracorporeal Adsorption Techniques

Contributions to nephrology, 2023, Vol.200, p.82

2023

Volltextzugriff (PDF)

High-volume hemofiltration does not protect human kidney endothelial and tubular epithelial cells from septic plasma-induced injury

Scientific reports, 2024-08, Vol.14 (1), p.18323-15, Article 18323

2024

Volltextzugriff (PDF)

Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications

Critical care (London, England), 2016-10, Vol.20 (1), p.283-283, Article 283

2016

Volltextzugriff (PDF)

Changes in central venous-to-arterial carbon dioxide tension induced by fluid bolus in critically ill patients

PloS one, 2021-09, Vol.16 (9), p.e0257314-e0257314

2021

Volltextzugriff (PDF)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy

Critical care (London, England), 2020-10, Vol.24 (1), p.623-2, Article 623

2020

Volltextzugriff (PDF)

Inhibiting IL-6 in COVID-19: we are not sure

Critical care (London, England), 2020-07, Vol.24 (1), p.463-463, Article 463

2020

Volltextzugriff (PDF)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?

Critical care (London, England), 2020-09, Vol.24 (1), p.551-551, Article 551

2020

Volltextzugriff (PDF)

Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure

Critical care (London, England), 2020-08, Vol.24 (1), p.482-482, Article 482

2020

Volltextzugriff (PDF)

The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure

Critical care (London, England), 2020-05, Vol.24 (1), p.271-271, Article 271

2020

Volltextzugriff (PDF)

Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney

Annals of intensive care, 2018-09, Vol.8 (1), p.91-7, Article 91

2018

Volltextzugriff (PDF)

Interventions to improve appropriateness of laboratory testing in the intensive care unit: a narrative review

Annals of intensive care, 2024-01, Vol.14 (1), p.9-9, Article 9

2024

Volltextzugriff (PDF)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider

Critical care (London, England), 2020-10, Vol.24 (1), p.603-2, Article 603

2020

Volltextzugriff (PDF)

Anti-Xa activity and hemorrhagic event: isn’t it time to consider time ?

Critical care (London, England), 2021-06, Vol.25 (1), p.1-210, Article 210

2021

Volltextzugriff (PDF)

1 – 25 von 514

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(467)
Mit Volltextzugriff
(440)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not

Editorial: New insights in sepsis pathogenesis and renal dysfunction: Immune mechanisms and novel management strategies

Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT

High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial

Cytokine removal in human septic shock: Where are we and where are we going?

Editorial: Community series in new insights in sepsis pathogenesis and renal dysfunction: immune mechanisms and novel management strategies: volume II

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure

Renal and neurological side effects of colistin in critically ill patients

Is prolonged intermittent renal replacement therapy actually safe for hemodynamically unstable patients

Anticoagulation Prophylaxis in Extracorporeal Adsorption Techniques

High-volume hemofiltration does not protect human kidney endothelial and tubular epithelial cells from septic plasma-induced injury

Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications

Changes in central venous-to-arterial carbon dioxide tension induced by fluid bolus in critically ill patients

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy

Inhibiting IL-6 in COVID-19: we are not sure

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?

Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure

The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure

Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney

Interventions to improve appropriateness of laboratory testing in the intensive care unit: a narrative review

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider

Anti-Xa activity and hemorrhagic event: isn’t it time to consider time ?

Suchergebnisse filtern